Back to search
RVF
Clinical trial pipeline · Data from ClinicalTrials.gov
See which RVF trials you may qualify forClinical trial pipeline · Data from ClinicalTrials.gov
See which RVF trials you may qualify forThis is a Phase 2, single-center, randomized placebo controlled trial of valsartan (an angiotensin receptor blocker) in adults with pulmonary arterial hypertens…
The objectives of the RELIEVE-PAH study are to obtain first-in-human experience with the study device in patients with severe pulmonary arterial hypertension, i…
Cardiovascular disease is the leading cause of mortality in the US, accounting for 45% of all deaths. Chronic Heart Failure (CHF) is now understood to be a mult…
The purpose of this study is to determine if transseptal extra-corporeal membrane oxygenation (ECMO) can bridge pulmonary hypertension- right heart failure (PH-…
Acute respiratory distress syndrome (ARDS) is an inflammatory injury of the lungs caused by various serious illnesses, such as a bacterial or viral lung infecti…
RACSMEI addresses the high burden of infectious diseases in low- and middle-income countries, including Cambodia, where limited surveillance and laboratory capa…
The purpose of this study is to evaluate the safety, tolerability and mechanistic effects of spironolactone, an aldosterone receptor antagonist, on sympathetic…
In this study, participants with complex fistulizing conditions will be treated with surgical interventions according to their clinic's standard practice. The…
PH-HFpEF patients will receive open-label doses of levosimendan and be periodically evaluated for safety in extended use.